These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

774 related articles for article (PubMed ID: 9330961)

  • 1. Frequency of stages of Alzheimer-related lesions in different age categories.
    Braak H; Braak E
    Neurobiol Aging; 1997; 18(4):351-7. PubMed ID: 9330961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic criteria for neuropathologic assessment of Alzheimer's disease.
    Braak H; Braak E
    Neurobiol Aging; 1997; 18(4 Suppl):S85-8. PubMed ID: 9330992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Post-mortem diagnosis of Alzheimer's disease].
    Thal DR; Braak H
    Pathologe; 2005 May; 26(3):201-13. PubMed ID: 15365765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert.
    Sassin I; Schultz C; Thal DR; Rüb U; Arai K; Braak E; Braak H
    Acta Neuropathol; 2000 Sep; 100(3):259-69. PubMed ID: 10965795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of stages of Alzheimer-related lesions in different age categories: concurrences and cautions.
    Ball MJ
    Neurobiol Aging; 1997; 18(4):375-6; discussion 389-92. PubMed ID: 9330964
    [No Abstract]   [Full Text] [Related]  

  • 6. Progression of Alzheimer-related neuritic plaque pathology in the entorhinal region, perirhinal cortex and hippocampal formation.
    Yilmazer-Hanke DM; Hanke J
    Dement Geriatr Cogn Disord; 1999; 10(2):70-6. PubMed ID: 10026378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vulnerability of cortical neurons to Alzheimer's and Parkinson's diseases.
    Braak H; Rüb U; Schultz C; Del Tredici K
    J Alzheimers Dis; 2006; 9(3 Suppl):35-44. PubMed ID: 16914843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brainstem tau pathology in Alzheimer's disease is characterized by increase of three repeat tau and independent of amyloid β.
    Uematsu M; Nakamura A; Ebashi M; Hirokawa K; Takahashi R; Uchihara T
    Acta Neuropathol Commun; 2018 Jan; 6(1):1. PubMed ID: 29298724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of neuronal changes in the course of Alzheimer's disease.
    Braak H; Braak E
    J Neural Transm Suppl; 1998; 53():127-40. PubMed ID: 9700651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of the neuropathology of Alzheimer's disease.
    Braak H; Braak E
    Acta Neurol Scand Suppl; 1996; 165():3-12. PubMed ID: 8740983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative autoradiography of [3H]forskolin binding sites in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid deposits.
    García-Jiménez A; Cowburn RF; Ohm TG; Bogdanovic N; Winblad B; Fastbom J
    Brain Res; 1999 Dec; 850(1-2):104-17. PubMed ID: 10629754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative autoradiographic study of [3H]cAMP binding to cytosolic and particulate protein kinase A in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid deposits.
    Bonkale WL; Cowburn RF; Ohm TG; Bogdanovic N; Fastbom J
    Brain Res; 1999 Feb; 818(2):383-96. PubMed ID: 10082824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathological diagnosis of Alzheimer's disease: a perspective from longitudinal clinicopathological studies.
    Dickson DW
    Neurobiol Aging; 1997; 18(4 Suppl):S21-6. PubMed ID: 9330981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of stages of Alzheimer-related lesions in different age categories.
    Silverman W; Wisniewski HM; Bobinski M; Wegiel J
    Neurobiol Aging; 1997; 18(4):377-9; discussion 389-92. PubMed ID: 9330965
    [No Abstract]   [Full Text] [Related]  

  • 15. Pattern of brain destruction in Parkinson's and Alzheimer's diseases.
    Braak H; Braak E; Yilmazer D; de Vos RA; Jansen EN; Bohl J
    J Neural Transm (Vienna); 1996; 103(4):455-90. PubMed ID: 9617789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease. The density of amygdalar neuritic plaques is associated with the severity of neurofibrillary pathology and the degree of beta-amyloid protein deposition in the cerebral cortex.
    Yilmazer-Hanke DM
    Acta Anat (Basel); 1998; 162(1):46-55. PubMed ID: 9789108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological substrates of cognitive decline in Alzheimer's disease.
    Giannakopoulos P; Gold G; von Gunten A; Hof PR; Bouras C
    Front Neurol Neurosci; 2009; 24():20-29. PubMed ID: 19182459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathological stageing of Alzheimer-related changes.
    Braak H; Braak E
    Acta Neuropathol; 1991; 82(4):239-59. PubMed ID: 1759558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alzheimer's disease: lesions and their progression].
    Duyckaerts C; Colle MA; Delatour B; Hauw JJ
    Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
    Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
    Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.